Treatment Outcomes of Dynamic Hip Screws Versus Short Intramedullary Nails for Extra-capsular Fragility Hip Fractures

Tarik Al-Dahan1, Siddhartha Murhekar2, Nimesh Patel3

  • 1Trauma and Orthopaedics, East Kent Hospitals University NHS Foundation Trust, Canterbury, GBR.

Cureus
|September 5, 2024
PubMed

Insights

Short intramedullary (IM) nails for hip fractures led to faster hospital discharge compared to dynamic hip screws (DHS). This study suggests IM nails may offer benefits, though larger trials are needed.

Area of Science:

  • Orthopedic Surgery
  • Trauma Surgery
  • Geriatric Medicine

Background:

  • Hip fractures are a significant cause of emergency department visits in the UK, straining hospital resources.
  • The choice of implant for treating extracapsular hip fractures impacts patient outcomes.

Purpose of the Study:

  • To compare patient outcomes between dynamic hip screws (DHS) and short cephalomedullary nails for extracapsular hip fractures.
  • To identify differences in recovery and mortality rates associated with each implant type.

Main Methods:

  • Retrospective study of 52 patients with extracapsular hip fractures treated at an NHS trust.
  • Data collected from patient records, including fracture classification and implant type.
  • Comparison of variables such as discharge time, 30-day mortality, and operating time.

Main Results:

  • Patients treated with short intramedullary (IM) nails had a significantly faster average hospital discharge (8.4 days) compared to dynamic hip screws (DHS) (11 days) (P=0.03).
  • 30-day mortality rates were similar: 7% for short IM nails and 6% for DHS (P=0.69).
  • Mean operating times were comparable: 58.03 minutes for short IM nails and 58.11 minutes for DHS (P=0.98).

Conclusions:

  • Short IM nails are associated with quicker hospital discharge, potentially due to reduced postoperative pain.
  • While IM nails offer mechanical advantages and are used for complex fractures, outcomes were similar to extramedullary devices in this study.
  • Larger randomized trials are recommended to confirm findings and mitigate potential bias in retrospective studies.